68 pending office actions • 41 art units • 66 examiners • 0 of 68 (0%) have an AI response strategy ready • 72 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 18 (26%) |
| §103 only | 16 (24%) |
| §112 only | 4 (6%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 1 (1%) |
| Multi-statute (no §101) | 28 (41%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.7% |
| DUNN, MCKENZIE A | 2 | 53.8% | +55.3% |
| ROBINSON, KYLE G | 1 | 11.8% | +16.7% |
| SALVATORE, LYNDA | 1 | 64.0% | +19.4% |
| ADAMS, WILLIAM PATRICK | 1 | — | — |
| CAMMARATA, MICHAEL ROBERT | 1 | 69.7% | +34.8% |
| LAGOY, KYRA RAND | 1 | 11.8% | -14.3% |
| HOFFPAUIR, ANDREW ELI | 1 | 41.8% | +50.4% |
| HENSON, DEVIN B | 1 | 65.1% | +43.5% |
| PARK, EDWARD | 1 | 82.2% | +18.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17699053 | GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS | SMITH, EMILIE ALINE | 169d overdue |
| 18061672 | PLASMON-ENHANCED FLUORO-DOT ASSAYS | LUSI, ELLIS FOLLETT | 66d overdue |
| 18311991 | METHODS FOR TREATING OR PREVENTING HEADACHE DISORDERS | SULLIVAN, DENNIS JOHN | 58d overdue |
| 17786473 | METHOD OF MEASURING CELL-FREE DNA IN SURGICAL DRAIN FLUID TO SELECT ADJUVANT THERAPY | HOPPE, EMMA RUTH | 50d overdue |
| 18405437 | DEPRESSION BRAIN COMPUTER INTERFACE FOR THE QUANTITATIVE ASSESSMENT OF MOOD STATE AND FOR BIOFEEDBACK FOR MOOD ALTERATION | NGUYEN, HUONG Q | 16d overdue |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 11d overdue |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | WORSHAM, JESSICA N | 8d overdue |
| 18261483 | MHC-INDEPENDENT TCRs AND METHODS OF MAKING AND USING SAME | NICKOL, GARY B | 2d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18638327 | DEEP NEURAL NETWORKS FOR OUTCOME-ORIENTED PREDICTIONS | PARK, EDWARD | 62d |
| 19105243 | CONVOLUTIONAL NEURAL NETWORK CLASSIFICATION OF PRETREATMENT BIOPSIES | ROBINSON, KYLE G | — |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | — |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | — |
| 18817716 | SYSTEMS AND METHODS FOR ELECTROMYOMETRIAL IMAGING | HOFFPAUIR, ANDREW ELI | — |
| 18812459 | Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics | HENSON, DEVIN B | — |
| 17798514 | CSF PHOSPHORYLATED TAU AND AMYLOID BETA PROFILES AS BIOMARKERS OF TAUOPATHIES | DUNN, MCKENZIE A | — |
| 17422051 | MULTIPLEXED ASSAY AND METHODS OF USE THEREOF | DUNN, MCKENZIE A | — |
| Art Unit | Apps |
|---|---|
| 1632 | 3 |
| 1678 | 3 |
| 3685 | 2 |
| 3791 | 2 |
| 3783 | 2 |
| 1635 | 2 |
| 1675 | 2 |
| 1644 | 2 |
| 1643 | 2 |
| 1638 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105243 | CONVOLUTIONAL NEURAL NETWORK CLASSIFICATION OF PRETREATMENT BIOPSIES | ROBINSON, KYLE G | 3685 | §101§103§112 | Non-Final OA | — | Pending | Feb 20, 2025 |
| 19028550 | BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS | SALVATORE, LYNDA | 1789 | DP | Final Rejection | — | Pending | Jan 17, 2025 |
| 18980157 | SYSTEMS AND METHODS FOR AUTOMATED ELECTROCARDIOGRAM (ECG) INTERPRETATION OF WIDE COMPLEX RHYTHMS | ADAMS, WILLIAM PATRICK | — | §103 | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18970827 | COMPUTATIONAL REFOCUSING-ASSISTED DEEP LEARNING | CAMMARATA, MICHAEL ROBERT | — | §103 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18855529 | SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING | LAGOY, KYRA RAND | 3685 | §101§103§112 | Non-Final OA | 11d overdue | Pending | Oct 09, 2024 |
| 18817716 | SYSTEMS AND METHODS FOR ELECTROMYOMETRIAL IMAGING | HOFFPAUIR, ANDREW ELI | — | §101§103§112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18812459 | Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics | HENSON, DEVIN B | — | §101§102§103 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18638327 | DEEP NEURAL NETWORKS FOR OUTCOME-ORIENTED PREDICTIONS | PARK, EDWARD | 2675 | §101§103 | Non-Final OA | 62d | Pending | Apr 17, 2024 |
| 18682707 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN PERFUSION | LANDSMAN, ROBERT S | — | §103 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18434796 | PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES | BAEK, JONGHWAN NMN | — | §102§103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18416578 | SYSTEMS AND METHODS FOR ATTENUATION COMPENSATION IN SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) | SORRIN, AARON JOSEPH | 2672 | §112 | Final Rejection | — | Pending | Jan 18, 2024 |
| 18579811 | METHODS OF DETECTING PENTASACCHARIDES AND TREATMENT AND MONITORING OF LYSOSOMAL STORAGE DISEASE | FRITCHMAN, REBECCA M | 1759 | §103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18405437 | DEPRESSION BRAIN COMPUTER INTERFACE FOR THE QUANTITATIVE ASSESSMENT OF MOOD STATE AND FOR BIOFEEDBACK FOR MOOD ALTERATION | NGUYEN, HUONG Q | 3791 | §101§103§112 | Non-Final OA | 16d overdue | Pending | Jan 05, 2024 |
| 18400667 | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | LI, RUIXIANG | — | §102§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18394890 | ELECTRODE-DECOUPLED REDOX FLOW BATTERY | CHMIELECKI, SCOTT J | 1729 | §101§103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18567428 | SYSTEMS AND METHODS FOR MONITORING PHYSIOLOGICAL STATUS OF LIVING SUBJECT AND ADMINISTERING SUBSTANCES THEREFOR | TURKOWSKI, KAYLA MARIE | 3783 | §103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18516382 | COMPOSITIONS AND METHODS FOR SCARLESS WOUND HEALING IN DIABETES | ANTHOPOLOS, PETER | 1611 | §103§112 | Non-Final OA | 28d | Pending | Nov 21, 2023 |
| 18503495 | THERAPEUTIC SPLICE-SWITCHING OLIGONUCLEOTIDES FOR CANCER | SHIN, DANA H | 1635 | §102§103§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18286205 | COMPOSITIONS AND METHODS FOR TREATMENT OF CRX-MEDIATED RETINOPATHIES | BEHARRY, ZANNA MARIA | 1632 | §101§103 | Final Rejection | — | Pending | Oct 09, 2023 |
| 18480409 | CDK4/6 INHIBITORS AS A TREATMENT FOR CLONAL HEMATOPOIESIS | LEE, WILLIAM Y | 1623 | §102§103§112 | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18553411 | COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF | JAVANMARD, SAHAR | 1622 | §103Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18282933 | SURGICAL DRAIN FOR COLLECTION AND PRESERVATION OF TUMOR-ASSOCIATED BIOMARKERS IN SURGICAL DRAIN FLUID | VU, QUYNH-NHU HOANG | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18548755 | TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION FOR SUBARACHNOID HEMORRHAGES | STOKLOSA, JOSEPH A | 3700 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18278707 | MICROBIAL PRODUCTION OF POLYMERIC AMYLOID FIBERS | JOHNSON, TIRONE DEREK | 1675 | §102§103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18276710 | METHODS FOR DETECTING NEUROFILAMENT LIGHT CHAIN IN PLASMA AND CEREBROSPINAL FLUID | DRISCOLL, MAUREEN VARINA | 1644 | §101§102§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18231684 | MUSCLE RETENTION IN AGING AND DUCHENNE MUSCULAR DYSTROPHY (DMD) THROUGH S1P INHIBITION | YU, DAVID TUYANG | 1635 | §102§103§112Other | Non-Final OA | — | Pending | Aug 08, 2023 |
| 18364112 | METHODS FOR TREATING CANCER | HEES, OLIVER DRAGON | 1628 | §103§112 | Non-Final OA | 16d | Pending | Aug 02, 2023 |
| 18261483 | MHC-INDEPENDENT TCRs AND METHODS OF MAKING AND USING SAME | NICKOL, GARY B | 1643 | §102§112 | Final Rejection | 2d overdue | Pending | Jul 14, 2023 |
| 18260354 | ADJUSTABLE SEAL FOR FLUID MANAGEMENT SYSTEM | STUART, COLIN W | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18340417 | GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | 70d | Pending | Jun 23, 2023 |
| 18255655 | METHODS OF TREATING AND PREVENTING KIDNEY DISEASE | SEITZ, ANTHONY JOSEPH | 1629 | §102§103 | Non-Final OA | 30d | Pending | Jun 02, 2023 |
| 18318232 | METHODS FOR TREATING HER2-NEGATIVE OR HER2-LOW CANCER | LUNDE, GRACE HENRY | 1641 | §103§112 | Non-Final OA | 2d overdue | Pending | May 16, 2023 |
| 18317780 | SURFACE-MODIFIED ANASTOMOSIS DEVICE | FUBARA, BLESSING M | 1613 | §102§112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18036695 | MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE | TSAY, MARSHA M | 1656 | §101§102 | Final Rejection | 21d | Pending | May 12, 2023 |
| 18312940 | COMPOSITIONS, METHODS, AND SYSTEMS FOR CELL LABELING | BOESEN, CHRISTIAN C | 1684 | §102§112 | Non-Final OA | — | Pending | May 05, 2023 |
| 18311991 | METHODS FOR TREATING OR PREVENTING HEADACHE DISORDERS | SULLIVAN, DENNIS JOHN | 1642 | §103§112 | Final Rejection | 58d overdue | Pending | May 04, 2023 |
| 18137267 | DEFINED MATRIX FOR THE DIFFERENTIATION OF ISLETS | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Final Rejection | — | Pending | Apr 20, 2023 |
| 18298355 | UNSUPERVISED DISCOVERY OF TUMOR MICROENVIRONMENTAL COMMUNITIES | KALLAL, ROBERT JAMES | — | §103 | Non-Final OA | — | Pending | Apr 10, 2023 |
| 18297497 | SYSTEMS AND METHODS FOR COMPUTATIONAL DESIGN OF CRISPR GUIDE RNAS FOR STRAIN-SPECIFIC CONTROL OF MICROBIOTA CONSORTIA | CANTRELL, MARANDA SHURIE | — | §103 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18248191 | METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER | VU, JAKE MINH | 1618 | §103§112 | Non-Final OA | 53d | Pending | Apr 06, 2023 |
| 18043330 | SYNTHETIC HYBRID SPIDROIN-AMYLOID-MUSSEL FOOT PROTEIN FOR UNDERWATER ADHESION OF DIVERSE SURFACES | ZINGARELLI, SANDRA | 1653 | §103§112 | Non-Final OA | 12d | Pending | Feb 27, 2023 |
| 18168955 | METHODS OF DETERMINING COVID-19 MORTALITY RISK | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§102§103§112 | Non-Final OA | 9d | Pending | Feb 14, 2023 |
| 18164502 | CELLS AND METHODS OF USES AND MAKING THE SAME | SINGH, ANOOP KUMAR | 1632 | §103 | Non-Final OA | 70d | Pending | Feb 03, 2023 |
| 18162387 | COMPOSITIONS AND METHODS FOR SUSTAINED OXYGEN RELEASE TO ISCHEMIC TISSUES | SAEED, ALI S | 1616 | §102§103§112 | Final Rejection | — | Pending | Jan 31, 2023 |
| 18061672 | PLASMON-ENHANCED FLUORO-DOT ASSAYS | LUSI, ELLIS FOLLETT | 1677 | §103§112 | Non-Final OA | 66d overdue | Pending | Dec 05, 2022 |
| 18054503 | PARALLEL SINGLE-CELL REPORTER ASSAYS AND COMPOSITIONS | PHAM, KHAI QUYNH TIEN | 1684 | §103 | Final Rejection | 91d overdue | Pending | Nov 10, 2022 |
| 17923029 | METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION | BELYAVSKYI, MICHAIL A | 1644 | §103 | Non-Final OA | 105d overdue | Pending | Nov 03, 2022 |
| 17918933 | METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR ENHANCING THEIR UTILITY | BERKE-SCHLESSEL, DAVID W | 1651 | §103§112DPOther | Final Rejection | 70d | Pending | Oct 14, 2022 |
| 17918792 | SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS | YAO, LEI | 1642 | §112 | Final Rejection | 29d | Pending | Oct 13, 2022 |
| 17761594 | COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION | SINGH, SATYENDRA K | 1657 | §103 | Final Rejection | — | Pending | Oct 11, 2022 |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | WORSHAM, JESSICA N | 1615 | §102§103 | Non-Final OA | 8d overdue | Pending | Sep 30, 2022 |
| 17801776 | METHODS OF USE OF ANTI-TREM2 ANTIBODIES | WANG, CHANG YU | 1675 | §112Other | Non-Final OA | — | Pending | Aug 23, 2022 |
| 17798514 | CSF PHOSPHORYLATED TAU AND AMYLOID BETA PROFILES AS BIOMARKERS OF TAUOPATHIES | DUNN, MCKENZIE A | 1678 | §101§102§103§112 | Final Rejection | — | Pending | Aug 09, 2022 |
| 17786255 | CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME | ZHU, JIANJIAN | 1631 | §103Other | Final Rejection | 27d | Pending | Jun 16, 2022 |
| 17786473 | METHOD OF MEASURING CELL-FREE DNA IN SURGICAL DRAIN FLUID TO SELECT ADJUVANT THERAPY | HOPPE, EMMA RUTH | 1683 | §101§103Other | Non-Final OA | 50d overdue | Pending | Jun 16, 2022 |
| 17778079 | Methods and Compositions for Generating Functionally Mature Beta Cells and Uses Thereof | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Final Rejection | — | Pending | May 19, 2022 |
| 17735586 | SYSTEMS AND METHODS OF ADAPTIVE RADIOTHERAPY WITH CONVENTIONAL LINEAR PARTICLE ACCELERATOR (LINAC) RADIOTHERAPY DEVICES | VIRK, ADIL PARTAP S | 3798 | §103§112 | Non-Final OA | — | Pending | May 03, 2022 |
| 17731195 | Sensors for Aromatic Compounds and Methods of Making and Using Same | WARD, AARON DUREL | 1636 | §102§103§112 | Non-Final OA | — | Pending | Apr 27, 2022 |
| 17699053 | GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS | SMITH, EMILIE ALINE | 1686 | §101§102§103Other | Final Rejection | 169d overdue | Pending | Mar 18, 2022 |
| 17694679 | Automated Interpretation of Protein Capillary Electrophoresis Data | SCHULTZHAUS, JANNA NICOLE | 1685 | §101§103§112 | Final Rejection | — | Pending | Mar 15, 2022 |
| 17634843 | METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF | RAMADAN, OMAR | 1678 | §101§102§103§112 | Final Rejection | — | Pending | Feb 11, 2022 |
| 17628497 | PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES | JONES, DAMERON LEVEST | 1618 | §103 | Non-Final OA | 36d overdue | Pending | Jan 19, 2022 |
| 17610578 | AUDITORY PROSTHETIC DEVICES USING EARLY AUDITORY POTENTIALS AS A MICROPHONE AND RELATED METHODS | GEDEON, BRIAN T | 3796 | §103 | Non-Final OA | — | Pending | Nov 11, 2021 |
| 17501059 | METHODS OF DETECTION AND TREATMENT FOR CARDIOVASCULAR DISEASE AND FOOT WOUNDS | KASAYAN, KATRIEL BARCELLANO | 1600 | §103§112 | Final Rejection | — | Pending | Oct 14, 2021 |
| 17422051 | MULTIPLEXED ASSAY AND METHODS OF USE THEREOF | DUNN, MCKENZIE A | 1678 | §101§103 | Final Rejection | — | Pending | Jul 09, 2021 |
| 17291959 | CHIMERIC ANTIGEN RECEPTOR MEMORY-LIKE (CARML) NK CELLS AND METHODS OF MAKING AND USING SAME | SHUPE, ELIZABETH A | 1643 | §112 | Final Rejection | 78d overdue | Pending | May 06, 2021 |
| 17055946 | METHODS AND COMPOSITIONS FOR GENERATING CELLS OF ENDODERMAL LINEAGE AND BETA CELLS AND USES THEREOF | STAVROU, CONSTANTINA E | 1632 | §103Other | Final Rejection | — | Pending | Nov 16, 2020 |
| 16946215 | SPARSE CO-VARYING UNIT OF THE HUMAN GUT MICROBIOTA THAT DESCRIBES HEALTHY AND IMPAIRED COMMUNITY DEVELOPMENT | LIN, JERRY | 1685 | §101§112 | Non-Final OA | 46d | Pending | Jun 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial